1 Min Read
May 24 (Reuters) - Roche Holding Ag
* Says new data at ats add to body of evidence for roche’s esbriet (pirfenidone) in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.